CVS vs CI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CVS

50.7
AI Score
VS
CVS Wins

CI

47.1
AI Score

Investment Advisor Scores

CVS

51score
Recommendation
HOLD

CI

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CVS CI Winner
Revenue 140.16B 189.89B CVS
Net Income 3.31B 4.89B CVS
Net Margin 2.4% 2.6% CVS
Operating Income 5.03B 8.95B CVS
ROE 7.8% 7.8% CVS
ROA 2.1% 2.2% CVS
Total Assets 157.08B 220.11B CVS
Cash 6.30B 5.19B CI
Current Ratio 0.85 0.92 CVS

Relative Price Performance (Last 90 Days)

CVS 1M: +0.4% · 3M: +28.0% CI 1M: -3.1% · 3M: -1.5%

Current Technical Phase

CVS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.9% over 20 days), RSI 51

RSI (14): 51.3 · Price: $105.11

CI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $278.71

Fundamentals Snapshot

Metric CVS CI
Market Cap
Forward P/E 12.4 8.3
Trailing P/E 46.6 12.6
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.1%
EPS 2.26 22.90
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.